CELLULAR LONGEVITY, INC., DBA LOYAL

cellular-longevity-inc-dba-loyal-logo

Loyal is a biotechnology company developing medicines to extend dog lifespan. By developing drugs with the potential to slow the aging process, they aim to delay or prevent age-related diseases like cancer and dementia.

#SimilarOrganizations #People #Financial #Website #More

CELLULAR LONGEVITY, INC., DBA LOYAL

Social Links:

Industry:
Biotechnology Pet Veterinary

Founded:
2019-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.loyalfordogs.com

Status:
Active

Email Addresses:
[email protected]

Total Funding:
58 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Similar Organizations

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

kindred-biosciences-logo

Kindred Biosciences

Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.

Current Employees Featured

celine-halioua_image

Celine Halioua
Celine Halioua Founder & CEO @ Cellular Longevity, Inc., dba Loyal
Founder & CEO

Founder


celine-halioua_image

Celine Halioua

Investors List

ashley-mayer_image

Ashley Mayer

Ashley Mayer investment in Series A - Cellular Longevity, Inc., dba Loyal

claire-hughes-johnson_image

Claire Hughes Johnson

Claire Hughes Johnson investment in Series A - Cellular Longevity, Inc., dba Loyal

boxgroup_image

BoxGroup

BoxGroup investment in Series A - Cellular Longevity, Inc., dba Loyal

khosla-ventures_image

Khosla Ventures

Khosla Ventures investment in Series A - Cellular Longevity, Inc., dba Loyal

first-round-capital_image

First Round Capital

First Round Capital investment in Series A - Cellular Longevity, Inc., dba Loyal

lgf_image

LGF

LGF investment in Series A - Cellular Longevity, Inc., dba Loyal

quiet-capital_image

Quiet Capital

Quiet Capital investment in Series A - Cellular Longevity, Inc., dba Loyal

brianne-kimmel_image

Brianne Kimmel

Brianne Kimmel investment in Series A - Cellular Longevity, Inc., dba Loyal

the-longevity-fund_image

The Longevity Fund

The Longevity Fund investment in Series A - Cellular Longevity, Inc., dba Loyal

collaborative-fund_image

Collaborative Fund

Collaborative Fund investment in Series A - Cellular Longevity, Inc., dba Loyal

Official Site Inspections

http://www.loyalfordogs.com Semrush global rank: 2.44 M Semrush visits lastest month: 7.34 K

  • Host name: ec2-52-42-249-166.us-west-2.compute.amazonaws.com
  • IP address: 52.42.249.166
  • Location: Boardman United States
  • Latitude: 45.8491
  • Longitude: -119.7143
  • Metro Code: 810
  • Timezone: America/Los_Angeles
  • Postal: 97818

Loading ...

More informations about "Cellular Longevity, Inc., dba Loyal"

About us - Loyal

Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the healthspan and lifespan of dogs.See details»

Loyal - Crunchbase Company Profile & Funding

Contact Email [email protected] Loyal is a biotechnology company developing medicines to extend dog lifespan. By developing drugs with the โ€ฆSee details»

Loyal | Clinical trials

At Loyal, weโ€™re a clinical-stage veterinary medicine company developing drugs intended to extend the healthy lifespan of dogs. Weโ€™ve launched the STAY study โ€” a double-blinded, placebo โ€ฆSee details»

Cellular Longevity, Inc., dba Loyal - Email and contact information

Cellular Longevity, Inc., dba Loyal's email address is [email protected]. Where are Cellular Longevity, Inc., dba Loyalโ€™s headquarters? Cellular Longevity, Inc., dba Loyal's headquarters โ€ฆSee details»

Loyal for Dogs - LifeScienceHistory.com

Loyalfordogs.com. 1841 Market St. Flr 3. San Francisco, CA 94013. Company Info Year Established 2019. Contacts Celine Halioua Founder & CEO Sudharika Gogna COO. Company โ€ฆSee details»

Loyal - LinkedIn

Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives.See details»

Cellular Longevity Inc (dba Loyal) - VentureRadar

Website: https://loyalfordogs.com. Develops and conducts research on clinical-stage animal health drugs designed to extend the lifespan and enhance the health of dogs by targeting the โ€ฆSee details»

Loyal Company Profile - Office Locations, Competitors, Revenue

Loyal $38 m in total funding,. See insights on Loyal including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Independent Board Member - Celine Halioua

Our end goal is a revenue-creating sustainable, venture scale organization that develops and commercializes aging drugs (AKA - not a build-to-buy play) We have a number of tailwinds: โ€ฆSee details»

Loyal For Dogs - YouTube

Loyal is a clinical-stage veterinary medicine company. Weโ€™re developing drugs intended to delay and reverse aging in dogs, because we believe they deserve as many happy years as we can โ€ฆSee details»

FDA Center for Veterinary Medicine agrees Loyalโ€™s data supports ...

Nov 28, 2023 FDA Center for Veterinary Medicine agrees Loyalโ€™s data supports reasonable expectation of effectiveness for large dog lifespan extensionSee details»

Biotech startup Loyal announces $45m Series B financing to โ€ฆ

Mar 25, 2024 Loyal, a biotech company pioneering longevity drugs for dogs, announced it has completed its Series B funding round, securing $45 million in investment.The round was led by โ€ฆSee details»

Morris Animal Foundation Partners with Loyal

DENVER/June 7, 2021 โ€“ In an effort to improve canine health and longevity, Morris Animal Foundation, a nonprofit leader in advancing animal health, is partnering with Loyal, a biotech โ€ฆSee details»

Loyal Reaches FDA Milestone for its Drug to Extend Healthy โ€ฆ

Nov 28, 2023 Loyal is a biotech startup developing the first drugs intended to help dogs live longer, healthier lives. By targeting the underlying mechani sms of aging, Loyal hopes to โ€ฆSee details»

The Future for Dogs Looks Longer and Healthier

Feb 20, 2024 A San Francisco biotech company called Loyal aims to extend the lifespan of dogs using three drugs: LOY-001, LOY-002, and LOY-003. These drugs reduce the IGF-1 hormone โ€ฆSee details»

Prelude and Loyal: Collaborating to Extend Canine Lifespans

AUSTIN, Texas, April 19, 2024 /PRNewswire/ -- Loyal, the San Francisco-based company dedicated to improving the health and longevity of dogs, and Prelude, the leading animal โ€ฆSee details»

Loyalโ€™s latest milestone: the first longevity clinical study design ...

Mar 10, 2023 Some important news: Loyal has received protocol concurrence from the FDA on our companion dog longevity study. This means that the FDA has reviewed the scientific โ€ฆSee details»

Loyal Launches Nationwide, 1,000-Dog Clinical Trial for Drug to โ€ฆ

Feb 1, 2024 Tim Smith [email protected] 415-350-3019 Release Summary Biotech company Loyal launches nationwide, 1,000-dog clinical trial for its LOY-002 drug to extend โ€ฆSee details»

7 Most Faithful Dog Breeds That Never Let You Down

Mar 11, 2025 WorldAnimalFoundation.org is a leading digital platform advocating for animal rights, responsible pet ownership, and compassionate awareness. WAF is not a non-profit โ€ฆSee details»

Our LOY-002 clinical pilot study is now fully enrolled - Loyal Blog

Apr 11, 2023 Weโ€™ve now fully enrolled our first clinical study for LOY-002 โ€” the internal name for our daily tablet intended to extend lifespan and quality of life for older dogs.See details»

linkstock.net © 2022. All rights reserved